NPT
ABUS icon

National Philanthropic Trust’s Arbutus Biopharma ABUS Stock Holding History

National Philanthropic Trust’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-36,211
Closed -$112K – 254
2024
Q2 		$112K Hold
36,211
– – ﹤0.01% 248
2024
Q1 		$93.4K Sell
36,211
-1,477
-4% -$3.83K ﹤0.01% 261
2023
Q4 		$94.2K Buy
+37,688
New +$73.8K ﹤0.01% 301

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

National Philanthropic Trust's ABUS Position: Q3 2024 in Review

National Philanthropic Trust sold out of Arbutus Biopharma (ABUS) in Q3 2024, closing a stake of 36,211 shares — an estimated $112K sold.

National Philanthropic Trust first reported a position in ABUS in Q4 2023 and held it in 3 quarters. The position peaked at $112K in Q2 2024. 144 funds tracked by Wall St. Rank hold ABUS as of Q3 2024.

  • National Philanthropic Trust reported no remaining Arbutus Biopharma position as of Q3 2024 after selling out during the quarter.
  • National Philanthropic Trust sold 36,211 Arbutus Biopharma shares in Q3 2024, an estimated $112K.
  • National Philanthropic Trust first reported a position in Arbutus Biopharma in Q4 2023 and held it in 3 quarters.
  • National Philanthropic Trust's Arbutus Biopharma position peaked at $112K in Q2 2024.
  • 144 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2024.

Based on National Philanthropic Trust's 13F filing for Q3 2024, filed 15 May 2026.